CA - Sirona Biochem ends agreement for TFC-1067 with Rodan + Fields
-
Sirona Biochem ( OTCPK:SRBCF ) on Monday announced the termination of the Rodan + Fields agreement for supply and use of TFC-1067 in commercial formulations.
Allergan Aesthetics, a unit of AbbVie, will now be the sole licensee of the technology as per the agreement signed June 2022, the company said.
For further details see:
Sirona Biochem ends agreement for TFC-1067 with Rodan + Fields